Mar 21, 2019 / 02:00PM GMT
William B. Boni - Minerva Neurosciences, Inc. - VP of IR & Corporate Communications
Good morning. Welcome to the March 21, 2019 webcast of Minerva Neurosciences entitled - Schizophrenia, Disease Landscape and Forecast. My name is Bill Boni and I am the VP of investor relations at Minerva. Presenters today will include from Decision Resources Group or DRG, Ryan Sowers, M.S.; and Dr. Emma McFadden, Ph. D.
From the University of Georgia, Dr. Gregory P. Strauss, Ph. D., a key opinion leader in the areas of negative symptoms and schizophrenia. And from Minerva, Dr. Rémy Luthringer, Ph. D., Executive Chairman and Chief Executive Officer.
Today's presenters will highlight the evolving landscape of the market for treatments for schizophrenia, the importance of negative symptoms as a key unmet need in treating this disease and the potential role of roluperidone, an investigational agent in Phase III clinical trials in addressing this need.
Each presenter will take 15 minutes. And at the end, we will have a 15-minute question-and-answer period. Those of you wishing to submit
Minerva Neurosciences, Inc. - Special Call Transcript
Feb 08, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers